Genome BC invests in research that aligns with the needs of areas of strategic importance to British Columbia such as health, forestry, fisheries and aquaculture, agrifood, energy, mining and environment.
By working collaboratively with government, academia and industry, Genome BC’s goal is to translate the excellent research carried out in universities into applications that will ultimately generate social and economic benefits for BC and Canada.
Genome BC’s co-funding approach to research investment follows neither a government-only “granting council” model, nor an industry-only “portfolio management” approach. It is a unique approach that relies on collaborative research agreements and commitments to milestones and outputs, a model perhaps best described as “contract” research. It is important to note that discovery science is an engine that drives future developments in genomics and Genome BC funds research across the research continuum from discovery through application through translation.
Embracing Diversity to Achieve Precision and Increase Health Equity aims to inspire a paradigm shift in health research whereby biological, behavioural, social and environmental diversity and structural determinants of health are considered and integrated.
Status: Open Learn MoreGeneSolve supports projects providing solutions challenges from users across industry sectors. This user driven program is unique in that it encourages a collaborative research approach between industry users and academia.
Status: Open Learn MoreAs part of its innovation mandate, Genome BC is launching the Genomics Innovation Fund (GIF) to support the advancement of innovation projects in BC.
Status: Open Learn MoreGenome British Columbia and Genome Alberta will support implementation research designed to accelerate the development and adoption of genomics infrastructure and genomics-enabled technologies to improve healthcare within our jurisdiction’s unique health system.
Status: Open Learn MoreDoes your company have a clear pathway to commercialization for an innovative life science technology? Learn more about Genome BC's I² program that provides early stage commercialization support for companies developing BC-based technologies.
Status: Open Learn MoreGenomics has progressed to a point where research discoveries are providing tangible utility with application in the real world — commercialization is feasible. As part of our commitment to drive commercialization and translation Genome BC supports entrepreneurships and the acceleration of emerging companies in the life sciences through our partnership.
Status: Open Learn MoreThe goal of the Sector Innovation Program is to support projects that will address the needs of each key sector and have the potential to generate social, environmental and economic benefits for British Columbia in the future.
Status: Open Learn MoreThe Societal Issues Intake 4 (SOC4) provides an opportunity for researchers to explore and test countermeasures to local challenges of adopting genomics testing in BC’s healthcare system.
Status: Open Learn More